Information Provided By:
Fly News Breaks for March 16, 2016
PTX
Mar 16, 2016 | 18:21 EDT
Oppenheimer analyst Carlos Solorzano downgraded Pernix Therapeutics to Perform from Outperform following the company's Q4 results. The analyst cites lower script and revenue growth as well as debt risks for the rating change.
News For PTX From the Last 2 Days
There are no results for your query PTX